Guanhao Biotech Co.,Ltd.

SZSE:300238 Stock Report

Market Cap: CN¥3.4b

Guanhao BiotechLtd Management

Management criteria checks 1/4

Guanhao BiotechLtd's CEO is Feng Zhao, appointed in Jan 2025, has a tenure of less than a year. directly owns 0.005% of the company’s shares, worth CN¥178.07K. The average tenure of the management team and the board of directors is 1.7 years and 4.9 years respectively.

Key information

Feng Zhao

Chief executive officer

CN¥1.6m

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.005%
Management average tenure1.7yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

Solid Earnings May Not Tell The Whole Story For Guanhao BiotechLtd (SZSE:300238)

Nov 04
Solid Earnings May Not Tell The Whole Story For Guanhao BiotechLtd (SZSE:300238)

Subdued Growth No Barrier To Guanhao Biotech Co.,Ltd. (SZSE:300238) With Shares Advancing 38%

Oct 24
Subdued Growth No Barrier To Guanhao Biotech Co.,Ltd. (SZSE:300238) With Shares Advancing 38%

Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking

Sep 02
Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking

Guanhao Biotech Co.,Ltd. (SZSE:300238) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Jun 07
Guanhao Biotech Co.,Ltd. (SZSE:300238) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 26% Share Price Plunge Could Signal Some Risk

Apr 23
Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 26% Share Price Plunge Could Signal Some Risk

Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 32% Share Price Surge Not Quite Adding Up

Mar 09
Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 32% Share Price Surge Not Quite Adding Up

CEO

Feng Zhao (46 yo)

less than a year

Tenure

CN¥1,617,200

Compensation

Mr. Feng Zhao is General Manager of Guanhao Biotech Co. Ltd. since 2025. Mr. Feng Zhao was Deputy General Manager at Guanhao Biotech Co., Ltd.since February 3, 2020 until 2025.

Leadership Team

NamePositionTenureCompensationOwnership
Feng Zhao
General Managerless than a yearCN¥1.62m0.0052%
CN¥ 178.1k
Xu Qingrong
Deputy GM & Secretary1.7yrsCN¥584.90kno data
Junhui Zhao
Deputy General Manager1.7yrsCN¥918.60k0.0057%
CN¥ 193.5k
Zhen You
Deputy General Manager3.8yrsCN¥888.60kno data
Huaixin Hou
Deputy General Manager1.7yrsCN¥701.30kno data
Xianggui Lin
Deputy General Manager1.7yrsCN¥701.30kno data
Ruofeng Yi
Chief Financial Officer1.1yrsno datano data
Guofeng Xu
Chief Technology Officerno dataCN¥541.70kno data

1.7yrs

Average Tenure

44.5yo

Average Age

Experienced Management: 300238's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Xinzhi Wang
Vice Chairman4.6yrsCN¥1.15mno data
Chao Deng
Independent Director1.7yrsCN¥53.00kno data
Jianyi Zhao
Non-Employee Supervisor4.9yrsno datano data
Dan Tian
Chairman of the Supervisory Board4.9yrsno datano data
Junmei Han
Independent Director4.9yrsCN¥100.00kno data
Feng Sun
Non-Independent Director4.9yrsno datano data
Yongming Zhang
Non-Independent Chairman6.8yrsno datano data
Shuangbing Xian
Supervisor4.9yrsno datano data

4.9yrs

Average Tenure

53yo

Average Age

Experienced Board: 300238's board of directors are considered experienced (4.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 08:28
End of Day Share Price 2025/02/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guanhao Biotech Co.,Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xin ZhangAJ Securities Co., Ltd
Hui ChenBohai Securities Co., Ltd.
YANG QIAOChangjiang Securities Co. LTD.